Evaluation of hospital palliative care teams: strengths and weaknesses of the before-after study design and strategies to improve it

Palliat Med. 2009 Jan;23(1):23-8. doi: 10.1177/0269216308098802. Epub 2008 Oct 24.

Abstract

Hospital palliative care teams (HPCTs) are well established as multi-professional services to provide palliative care in an acute hospital setting and are increasing in number. However, there is still limited evaluation of them, in terms of efficacy and effectiveness. The gold standard method of evaluation is a randomised control trial, but because of methodological (e.g., randomisation), ethical and practical difficulties such trials are often not possible. HPCT is a complex intervention, and the specific situation in palliative care makes it challenging to evaluate (e.g., distress and cognitive impairment of patients). The quasi-experimental before-after study design has the advantage of enabling an experimental character without randomisation. But this has other weaknesses and is prone to bias, for example, temporal trends and selection bias. As for every study design, avoidance and minimisation of bias is important to improve validity. Therefore, strategies of selecting an appropriate control group or time series and applying valid outcomes and measurement tools help reducing bias and strengthen the methods. Special attention is needed to plan and define the design and applied method.

Publication types

  • Review

MeSH terms

  • Delivery of Health Care / organization & administration
  • Delivery of Health Care / standards
  • Hospitals
  • Humans
  • Palliative Care* / organization & administration
  • Palliative Care* / standards
  • Patient Care Team* / organization & administration
  • Patient Care Team* / standards
  • Quality of Health Care* / organization & administration
  • Quality of Health Care* / standards
  • Randomized Controlled Trials as Topic
  • Terminal Care* / organization & administration
  • Terminal Care* / standards